UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
Multiple myeloma - The Lancet
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES